Symphony Financial’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$283K Buy
729
+36
+5% +$13.4K 0.03% 276
2026
Q1
$202K Buy
+693
New +$228K 0.03% 308
2025
Q4
Sell
-763
Closed -$245K 295
2025
Q3
$245K Sell
763
-1,868
-71% -$581K 0.03% 244
2025
Q2
$256K Buy
+2,631
New +$1.06M 0.03% 219
2025
Q1
Sell
-590
Closed -$230K 131
2024
Q4
$230K Buy
+590
New +$247K 0.04% 207

Other funds holding ELV

Symphony Financial's ELV Position: Q2 2026 in Review

Symphony Financial increased its Elevance Health (ELV) stake by 5.2% in Q2 2026, buying an estimated $13.4K and bringing the position to 729 shares worth $283K. The position accounts for 0.03% of the portfolio, ranked #276.

Symphony Financial first reported a position in ELV in Q4 2024 and has held it in 5 quarters since. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Symphony Financial held 729 shares of Elevance Health worth $283K as of Q2 2026.
  • Symphony Financial bought 36 Elevance Health shares in Q2 2026, an estimated $13.4K.
  • Elevance Health made up 0.03% of Symphony Financial's portfolio in Q2 2026, its #276 holding.
  • Symphony Financial first reported a position in Elevance Health in Q4 2024 and has held it in 5 quarters since.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Symphony Financial's 13F filing for Q2 2026, filed 4 Aug 2026.